Biologic Therapies for Giant Cell Arteritis
Robert Harrington,* Shamma Ahmad Al Nokhatha,* Richard Conway Department of Rheumatology, St. James’s Hospital, Dublin, Ireland*These authors contributed equally to this workCorrespondence: Richard ConwayDepartment of Rheumatology, St. James’s Hospital, James Street, Dublin 8, Ir...
Saved in:
Main Authors: | Harrington R, Al Nokhatha SA, Conway R |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/22c6799b78d44b8195de3ff95920067f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)
by: Alfred Mahr, et al.
Published: (2021) -
Isquemia de extremidades inferiores secundaria a arteritis de la arteria temporal
by: Zárate B.,Cristian, et al.
Published: (2020) -
Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements
by: Dammacco R, et al.
Published: (2020) -
A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
by: Hoon E, et al.
Published: (2019) -
Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment
by: Idil Esen, et al.
Published: (2021)